검색어: infuzijas (라트비아어 - 영어)

insulfna infuzijas (psii)
insulin infusion (csii):

pirms infuzijas pulveris ir jaizškidina.
the powder will be dissolved before it can be infused.

var turet infuzijas suknf lfdz 37c sešas dienas.
may be kept in an infusion pump at up to 37c for 6 days

atryn 1750 sv pulveris infuzijas škiduma pagatavošanai antithrombin alfa
atryn 1750 iu powder for solution for infusion antithrombin alfa

ir pieradita saderiba ar pvh infuzijas caurulem ar iekšejo filtru.
compatibility with pvc infusion lines with in-line filters has been established.

tapec infuzijas laika ieteicams kontrolet glikozes lfmeni pacienta asinfs.
monitoring of the patient's blood glucose during infusion is therefore recommended.

infuzijas komplekts jamaina ik pa 48 stundam, lietojot aseptisku tehniku, to iestiprinot.
the infusion set should be changed every 48 hours using aseptic technique when inserting the infusion set.

gadijuma, ja at aktivitate parsniedz 120%, infuzijas atrumu samazina par 30%.
in case the at activity level is greater than 120% decrease the infusion rate by 30%.

sajaucot velosulin ar infuziju š1$idrumiem, neparedzamu insulfna daudzumu adsorbes infuzijas materials.
upon mixing velosulin with infusion fluids an unpredictable amount of insulin will be absorbed to the infusion material.

pacientam jal)em vera arsta noradfjumi par bazalo infuzijas komponentu un ar edienreizi saistfto bolus devu.
the patient should follow the instructions from the physician about the basal infusion rate and the mealtime insulin boluses to be taken.

ne velak ka 30 minušu laika pec injekcijas vai infuzijas jaietur maltfte vai jaaped og!hidratus saturoša uzkoda.
an injection or infusion should be followed within 30 minutes by a meal or snack containing carbohydrates.

kirurgiskiem pacientiem nepieciešamas uzturošas devas lielumu, ko ievada nepartrauktas infuzijas veida, nosaka pec šadas formulas:
the required maintenance dose for surgical patients is given as a continuous infusion and is determined using the following formula:

kas attiecas uz saderfbu ar insulfna infuzijas sukl)iem, rezervuariem, katetriem un adatam skatft apakšpunktu 6.6 .
concerning compatibility with insulin infusion pumps, reservoirs, catheters and needles, see section 6.6.

ja ievada ar psii, infuzijas sukl)a rezervuara, kura ir velosulin, nedrfkst pievienot citus arstnieciskus preparatus vai citus insulfnus.
when administered by csii no other medicinal products or other insulin products should be mixed in the reservoir of the infusion pump with velosulin.

atškaiditais produkts jaievada intravenozas infuzijas veida, izmantojot sterilu, vienreizejai lietošanai paredzetu šlirci vai infuzijas maisu ar 0, 22 mikronu filtru ievades caurule.
the reconstituted product should be administered by intravenous infusion using a sterile disposable syringe or an infusion bag wit h a 0.22 micron pore size in-line filter.

atryn 1750 sv pulveris infuziju škiduma pagatavošanai antithrombin alfa
atryn 1750 iu powder for solution for infusion antithrombin alfa